JP2024532159A5 - - Google Patents
Info
- Publication number
- JP2024532159A5 JP2024532159A5 JP2024509415A JP2024509415A JP2024532159A5 JP 2024532159 A5 JP2024532159 A5 JP 2024532159A5 JP 2024509415 A JP2024509415 A JP 2024509415A JP 2024509415 A JP2024509415 A JP 2024509415A JP 2024532159 A5 JP2024532159 A5 JP 2024532159A5
- Authority
- JP
- Japan
- Prior art keywords
- seq
- cfc
- cil
- amino acid
- acid sequence
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Applications Claiming Priority (5)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US202163235259P | 2021-08-20 | 2021-08-20 | |
| US202163235261P | 2021-08-20 | 2021-08-20 | |
| US63/235,261 | 2021-08-20 | ||
| US63/235,259 | 2021-08-20 | ||
| PCT/EP2022/073146 WO2023021170A2 (en) | 2021-08-20 | 2022-08-19 | Fusion proteins for treating atopic dermatitis |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2024532159A JP2024532159A (ja) | 2024-09-05 |
| JP2024532159A5 true JP2024532159A5 (https=) | 2025-08-21 |
Family
ID=83280140
Family Applications (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2024509411A Pending JP2024532158A (ja) | 2021-08-20 | 2022-08-19 | アトピー性皮膚炎を治療するためのホモ二量体融合タンパク質 |
| JP2024509415A Pending JP2024532159A (ja) | 2021-08-20 | 2022-08-19 | アトピー性皮膚炎を治療するための融合タンパク質 |
Family Applications Before (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2024509411A Pending JP2024532158A (ja) | 2021-08-20 | 2022-08-19 | アトピー性皮膚炎を治療するためのホモ二量体融合タンパク質 |
Country Status (7)
| Country | Link |
|---|---|
| US (2) | US20250325630A1 (https=) |
| EP (2) | EP4388005A2 (https=) |
| JP (2) | JP2024532158A (https=) |
| AU (2) | AU2022331122A1 (https=) |
| CA (2) | CA3227725A1 (https=) |
| MX (2) | MX2024002148A (https=) |
| WO (2) | WO2023021171A1 (https=) |
Families Citing this family (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2025141037A1 (en) * | 2023-12-28 | 2025-07-03 | Elanco Animal Health Gmbh | Il-4/il-13 and il-4/il-13/il-31 receptor trap constructs |
Family Cites Families (37)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4447233A (en) | 1981-04-10 | 1984-05-08 | Parker-Hannifin Corporation | Medication infusion pump |
| US4439196A (en) | 1982-03-18 | 1984-03-27 | Merck & Co., Inc. | Osmotic drug delivery system |
| US4447224A (en) | 1982-09-20 | 1984-05-08 | Infusaid Corporation | Variable flow implantable infusion apparatus |
| US4487603A (en) | 1982-11-26 | 1984-12-11 | Cordis Corporation | Implantable microinfusion pump system |
| US4816567A (en) | 1983-04-08 | 1989-03-28 | Genentech, Inc. | Recombinant immunoglobin preparations |
| US4596556A (en) | 1985-03-25 | 1986-06-24 | Bioject, Inc. | Hypodermic injection apparatus |
| EP0216846B2 (en) | 1985-04-01 | 1995-04-26 | Celltech Limited | Transformed myeloma cell-line and a process for the expression of a gene coding for a eukaryotic polypeptide employing same |
| GB8601597D0 (en) | 1986-01-23 | 1986-02-26 | Wilson R H | Nucleotide sequences |
| US4790824A (en) | 1987-06-19 | 1988-12-13 | Bioject, Inc. | Non-invasive hypodermic injection device |
| US4941880A (en) | 1987-06-19 | 1990-07-17 | Bioject, Inc. | Pre-filled ampule and non-invasive hypodermic injection device assembly |
| GB8717430D0 (en) | 1987-07-23 | 1987-08-26 | Celltech Ltd | Recombinant dna product |
| US5064413A (en) | 1989-11-09 | 1991-11-12 | Bioject, Inc. | Needleless hypodermic injection device |
| US5312335A (en) | 1989-11-09 | 1994-05-17 | Bioject Inc. | Needleless hypodermic injection device |
| US5383851A (en) | 1992-07-24 | 1995-01-24 | Bioject Inc. | Needleless hypodermic injection device |
| GB9818110D0 (en) | 1998-08-19 | 1998-10-14 | Weston Medical Ltd | Needleless injectors and other devices |
| US6096002A (en) | 1998-11-18 | 2000-08-01 | Bioject, Inc. | NGAS powered self-resetting needle-less hypodermic jet injection apparatus and method |
| US6703360B2 (en) | 2000-04-07 | 2004-03-09 | Heska Corporation | Compositions and methods related to canine IgG and canine IL-13 receptors |
| US7696222B2 (en) | 2005-08-12 | 2010-04-13 | Merck Frosst Canada Ltd | Indole derivatives as CRTH2 receptor antagonists |
| US7666622B2 (en) * | 2005-10-19 | 2010-02-23 | Regeneron Pharmaceuticals, Inc. | Monomeric self-associating fusion polypeptides and therapeutic uses thereof |
| JP2010502224A (ja) * | 2006-09-08 | 2010-01-28 | アボット・ラボラトリーズ | インターロイキン１３結合タンパク質 |
| WO2009122748A1 (ja) * | 2008-04-04 | 2009-10-08 | 国立大学法人九州大学 | 呼吸器系疾患又はアレルギー性疾患の治療剤 |
| KR101335843B1 (ko) | 2008-08-20 | 2013-12-02 | 조에티스 엘엘씨 | 피롤로[2,3-ｄ]피리미딘 화합물 |
| US8637671B2 (en) | 2008-09-22 | 2014-01-28 | Merck Canada Inc. | Indole derivatives as CRTH2 receptor antagonists |
| CA2736571A1 (en) | 2008-09-22 | 2010-03-25 | Merck Frosst Canada Ltd. | Azaindole derivatives as crth2 receptor antagonists |
| WO2010031182A1 (en) | 2008-09-22 | 2010-03-25 | Merck Frosst Canada Ltd. | Indole derivatives as crth2 receptor antagonists |
| CA2752981C (en) | 2009-02-24 | 2013-11-12 | Merck Sharp & Dohme Corp. | Indole derivatives as crth2 receptor antagonists |
| KR101445012B1 (ko) | 2009-12-17 | 2014-09-26 | 머크 샤프 앤드 돔 코포레이션 | Ｓｙｋ 억제제로서의 아미노피리미딘 |
| US8790651B2 (en) | 2011-07-21 | 2014-07-29 | Zoetis Llc | Interleukin-31 monoclonal antibody |
| TWI682781B (zh) | 2013-07-11 | 2020-01-21 | 美商再生元醫藥公司 | 藉由投與ｉｌ－４ｒ抑制劑治療嗜酸性食道炎的方法 |
| CN106029697B (zh) | 2013-12-20 | 2021-06-04 | 英特维特国际股份有限公司 | 具有经修饰的ch2-ch3序列的犬抗体 |
| CA2980087A1 (en) | 2015-04-02 | 2016-10-06 | Intervet International B.V. | Antibodies to canine interleukin-4 receptor alpha |
| JP7116063B2 (ja) | 2016-12-14 | 2022-08-09 | インターベット インターナショナル ベー． フェー． | 選択的ヤヌスキナーゼ阻害剤としてのアミノピラゾール類 |
| US10093731B2 (en) | 2017-02-24 | 2018-10-09 | Kindred Biosciences, Inc. | Anti-IL31 antibodies for veterinary use |
| JP7657548B2 (ja) * | 2017-04-21 | 2025-04-07 | エランコ・ユーエス・インコーポレイテッド | 獣医学的使用のためのｉｌ４／ｉｌ１３受容体分子 |
| EP3480212B1 (en) * | 2017-11-03 | 2023-09-27 | Consejo Superior De Investigaciones Científicas | Il13ralpha2 peptide and its uses |
| EP3870601A4 (en) | 2018-10-25 | 2022-07-13 | Kindred Biosciences, Inc. | IL4/IL13 RECEPTOR MOLECULE FOR USE IN VETERINARY MEDICINE |
| US11548895B2 (en) | 2019-04-24 | 2023-01-10 | Elanco Us Inc. | Process for making crystalline 2-(3-(4-(7H-pyrrolo[2,3-d]pyrimidin-4-yl)-1H-pyrazol-1-yl)-1-(cyclopropylsulfonyl)azetidin-3-yl)acetonitrile |
-
2022
- 2022-08-19 JP JP2024509411A patent/JP2024532158A/ja active Pending
- 2022-08-19 CA CA3227725A patent/CA3227725A1/en active Pending
- 2022-08-19 JP JP2024509415A patent/JP2024532159A/ja active Pending
- 2022-08-19 WO PCT/EP2022/073147 patent/WO2023021171A1/en not_active Ceased
- 2022-08-19 CA CA3227816A patent/CA3227816A1/en active Pending
- 2022-08-19 US US18/684,254 patent/US20250325630A1/en active Pending
- 2022-08-19 EP EP22768646.6A patent/EP4388005A2/en active Pending
- 2022-08-19 MX MX2024002148A patent/MX2024002148A/es unknown
- 2022-08-19 AU AU2022331122A patent/AU2022331122A1/en active Pending
- 2022-08-19 US US18/684,365 patent/US20240368249A1/en active Pending
- 2022-08-19 AU AU2022331810A patent/AU2022331810A1/en active Pending
- 2022-08-19 EP EP22768647.4A patent/EP4388006A1/en active Pending
- 2022-08-19 MX MX2024002149A patent/MX2024002149A/es unknown
- 2022-08-19 WO PCT/EP2022/073146 patent/WO2023021170A2/en not_active Ceased
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2024010112A5 (https=) | ||
| JP4426315B2 (ja) | Ｏｘ４０ｒ結合剤 | |
| Kiehart et al. | Cytoplasmic myosin from Drosophila melanogaster. | |
| JP2013534812A5 (https=) | ||
| JP2021531826A5 (https=) | ||
| JP2020506898A5 (https=) | ||
| JP2017512479A5 (https=) | ||
| WO2010025369A2 (en) | Uses of il-22, il-17, and il-1 family cytokines in autoimmune diseases | |
| JPH05503011A (ja) | 高特異性分子集成体の促進 | |
| JP2009537139A5 (https=) | ||
| JP2001511347A5 (https=) | ||
| JP2005524385A5 (https=) | ||
| JPH03204896A (ja) | インターフェロンレセプター細胞外断片 | |
| JP2024532159A5 (https=) | ||
| JP2023522676A5 (https=) | ||
| RU2007134568A (ru) | Способы применения агонистов рецепторов гибели клеток и ингибиторов egfr | |
| KR20230005880A (ko) | 수의학적 사용을 위한 il4/il13 수용체 분자 | |
| JP2024532158A5 (https=) | ||
| JP2017506505A5 (https=) | ||
| JP2023524643A5 (https=) | ||
| JP2017525693A (ja) | 生物学的材料およびその用途 | |
| JP2004254703A (ja) | Ｔｎｆリガンド | |
| JP2023171909A5 (https=) | ||
| RU2002133470A (ru) | Специфичные в отношении вируса бешенства нейтрализующие моноклональные антитела человека и нуклеиновые кислоты, и связанные с ними способы | |
| ZA200101819B (en) | Mammalian transforming growth factor beta - 9. |